Duchenne muscular dystrophy (DMD) treatment ifetroban led to improvements in measures of heart function in a Phase 2 clinical ...
Columnist Shalom Lim and his partner work to create a legacy that resonates in the world of art and disability and beyond.
Entrada Therapeutics announced it has been cleared in the U.K. to start a Phase 1/2 clinical trial of ENTR-601-44, at increasing doses, in Duchenne muscular dystrophy (DMD) patients with a mutation in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback